Explore more publications!

French Industry Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.

Press releases published on March 2, 2026

Le secteur européen du carton réduit encore de 8 % son empreinte carbone fossile
Selma Blair and Trevor Donovan, 'Dancing with the Stars' Alumni, Join Cast in 'Ethan Almighty – Ethan’s Law'
DASI Announces inventory acquisition from Mesa Airlines to Support Fleet Transition
Avatier Appoints Intel-Exit Founder and 18-Patent Inventor Jose Picazo to Board to Advance AI-Powered IAM Platform
World Mobile Wins ITB Innovator 2026 Again, Launches Platform Turning Unlimited Connectivity into More Bookings
Spectro Cloud and 6WIND Collaborate to Accelerate High-Performance Cloud Networking with NVIDIA
Eurelectric Presidency urges EU leaders to safeguard the electricity market design
NP Unveils ‘MUA’H’ at MWC 2026: An AI-Powered Sanctuary for Workplace Mental Health
Beaujolais in Motion: The New Energy of the French Wine Region Captivating the U.S.
OSE Immunotherapeutics Accelerates Strategic Refocusing to Advance Late Stage Value Drivers Lusvertikimab and Tedopi®
OSE Immunotherapeutics accélère son recentrage stratégique autour de ses principaux leviers de création de valeur en phase avancée: Lusvertikimab et Tedopi®
[Press Release] Launch of a share buyback programme
Valneva annonce sa participation à des conférences investisseurs
Valneva to Participate in Upcoming Investor Conferences
newcleo subsidiary S.R.S. awarded USD 42 million contracts with Romania’s RATEN to build lead-cooled nuclear reactor research facilities
Egle Therapeutics and Consortium Partners Awarded €8 Million Grant from Horizon Europe to Advance Clinical Development of EGL-001 in Neoadjuvant Head and Neck Cancer
Vantiva Unveils New Hawk 5G FWA Home Gateway,  designed for 5G SA
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin au Japon pour la maladie liée aux IgG4

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions